This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roggero, R. Articles by Ben Mamoun, C. Search for Related Content PubMed PubMed Citation Articles by Roggero, R. Articles by Ben Mamoun, C.

Unraveling the Mode of Action of the Antimalarial Choline Analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae

Center for Microbial Pathogenesis,² Department of Genetics and Development Biology,³ Department of Pathology, University of Connecticut Health Center, Farmington, Connecticut 06030,⁴ Dynamique Moleculaire des Interactions Membranaires, CNRS UMR 5539, Universite Montpellier II, 34095 Montpellier Cedex 05, France¹

Received 18 February 2004/ Returned for modification 1 April 2004/ Accepted 16 April 2004

Pharmacological studies have indicated that the choline analog G25 is a potent inhibitor of Plasmodium falciparum growth in vitro and in vivo. Although choline transport has been suggested to be the target of G25, the exact mode of action of this compound is not known. Here we show that, similar to its effects on P. falciparum, G25 prevents choline entry into Saccharomyces cerevisiae cells and inhibits S. cerevisiae growth. However, we show that the uptake of this compound is not mediated by the choline carrier Hnm1. An hnm1 yeast mutant, which lacks the only choline transporter gene HNM1, was not altered in the transport of a labeled analog of this compound. Eleven yeast mutants lacking genes involved in different steps of phospholipid biosynthesis were analyzed for their sensitivity to G25. Four mutants affected in the de novo cytidyldiphosphate-choline-dependent phosphatidylcholine biosynthetic pathway and, surprisingly, a mutant strain lacking the phosphatidylserine decarboxylase-encoding gene PSD1 (but not PSD2) were found to be highly resistant to this compound. Based on these data for S. cerevisiae, labeling studies in P. falciparum were performed to examine the effect of G25 on the biosynthetic pathways of the major phospholipids phosphatidylcholine and phosphatidylethanolamine. Labeling studies in P. falciparum and in vitro studies with recombinant P. falciparum phosphatidylserine decarboxylase further supported the inhibition of both the de novo phosphatidylcholine metabolic pathway and the synthesis of phosphatidylethanolamine from phosphatidylserine. Together, our data indicate that G25 specifically targets the pathways for synthesis of the two major phospholipids, phosphatidylcholine and phosphatidylethanolamine, to exert its antimalarial activity.

This article has been cited by other articles:

• Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K., Puri, S. K., Bandyopadhyay, U. (2007). Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism. Antimicrob. Agents Chemother. 51: 696-706 [Abstract] [Full Text]  
• Witola, W. H., Pessi, G., El Bissati, K., Reynolds, J. M., Mamoun, C. B. (2006). Localization of the Phosphoethanolamine Methyltransferase of the Human Malaria Parasite Plasmodium falciparum to the Golgi Apparatus. J. Biol. Chem. 281: 21305-21311 [Abstract] [Full Text]  
• Pessi, G., Choi, J.-Y., Reynolds, J. M., Voelker, D. R., Mamoun, C. B. (2005). In Vivo Evidence for the Specificity of Plasmodium falciparum Phosphoethanolamine Methyltransferase and Its Coupling to the Kennedy Pathway. J. Biol. Chem. 280: 12461-12466 [Abstract] [Full Text]  
• Biagini, G. A., Pasini, E. M., Hughes, R., De Koning, H. P., Vial, H. J., O'Neill, P. M., Ward, S. A., Bray, P. G. (2004). Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104: 3372-3377 [Abstract] [Full Text]  
• Vial, H. J., Wein, S., Farenc, C., Kocken, C., Nicolas, O., Ancelin, M. L., Bressolle, F., Thomas, A., Calas, M. (2004). Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. USA 101: 15458-15463 [Abstract] [Full Text]